Ausgabe 2/2017
Inhalt (11 Artikel)
SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor
Yumei Ye, Mandeep Bajaj, Hsiu-Chiung Yang, Jose R. Perez-Polo, Yochai Birnbaum
Exploring the Role of TRPV and CGRP in Adenosine Preconditioning and Remote Hind Limb Preconditioning-Induced Cardioprotection in Rats
Amritpal Singh, Puneet Kaur Randhawa, Anjana Bali, Nirmal Singh, Amteshwar Singh Jaggi
Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture
Xiao-Ming Gao, Alan Tsai, Annas Al-Sharea, Yidan Su, Shirley Moore, Li-Ping Han, Helen Kiriazis, Anthony M. Dart, Andrew J. Murphy, Xiao-Jun Du
Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis
Mei-ping Wu, Yi-shuai Zhang, Xiangbin Xu, Qian Zhou, Jian-Dong Li, Chen Yan
Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study
Vanessa Pfetsch, Veronika Sanin, Andrea Jaensch, Dhayana Dallmeier, Ute Mons, Hermann Brenner, Wolfgang Koenig, Dietrich Rothenbacher
The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability
Robert S Rosenson, Kate Miller, Martha Bayliss, Robert J Sanchez, Marie T Baccara-Dinet, Daniela Chibedi-De-Roche, Beth Taylor, Irfan Khan, Garen Manvelian, Michelle White, Terry A. Jacobson
Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries
Robert S. Rosenson, Shravanthi R. Gandra, Jan McKendrick, Ricardo Dent, Heather Wieffer, Lung-I Cheng, Alberico L. Catapano, Paul Oh, G. Kees Hovingh, Erik S. Stroes
Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
Gianna Ferretti, Tiziana Bacchetti, Luis E. Simental-Mendía, Željko Reiner, Maciej Banach, Amirhossein Sahebkar
Study Design and Rationale of “A Multicenter, Open-Labeled, Randomized Controlled Trial Comparing MIdazolam Versus MOrphine in Acute Pulmonary Edema”: MIMO Trial
Alberto Dominguez-Rodriguez, Guillermo Burillo-Putze, Maria del Mar Garcia-Saiz, Ana Aldea-Perona, Magali González-Colaço Harmand, Oscar Mirò, Pedro Abreu-Gonzalez, Miguel Angel Pinillos-Echeverría, Miguel Alberto Rizzi, Francisco Javier Martin-Sanchez, Coral Suero-Mendez, Rafael Calvo-Rodriguez, Cesar Carballo-Carmona, Victor Gil, Pablo Herrero, Angel Ascensino Bajo Bajo, Pascual Piñera Salmeron
The Effect of Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitors on Cardiometabolic Profile; Beyond the Hypoglycaemic Action
Eirini Lioudaki, Emmanouil S. Androulakis, Martin Whyte, Konstantinos G. Stylianou, Eugenios K. Daphnis, Emmanouil S. Ganotakis
Melatonin as an Agent for Cardioprotection in Patients with ST-Elevation Myocardial Infarction and Short Ischaemic Time
Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Russel J. Reiter